Nova Patents
IL255465B

Alvocidib prodrugs having increased bioavailability

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

55 members in 20 offices

This recordMember, by publication datePriority claim10 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
201562163188United States of AmericaP
201562163188United States of AmericaP
2016033099United States of AmericaW
2016033099United States of AmericaW
62163188–––
PCTUS2016033099–––
US201562163188P–––
WO2016US33099–––

Members55

Family members, oldest first
DocumentOfficeKind
CA2985804A1CanadaA1
US2016340376A1United States of AmericaA1
WO2016187316A1World Intellectual Property Organization (WIPO)A1
US9758539B2United States of AmericaB2
US2017334938A1United States of AmericaA1
AU2016264212A1AustraliaA1
MX2017014645AMexicoA
IL255465AIsraelA
KR20180019561ARepublic of KoreaA
CN107849073AChinaA
EP3298021A1European Patent Office (EPO)A1
JP2018517686AJapanA
BR112017024933A2BrazilA2
JP2018199694AJapanA
US10259835B2United States of AmericaB2
EP3298021B1European Patent Office (EPO)B1
HK1251941AHong Kong, ChinaA
HK1251941A1Hong Kong, ChinaA1
JP6510075B2JapanB2
US2019177350A1United States of AmericaA1
RU2017143776ARussian FederationA
DK3298021T3DenmarkT3
PT3298021TPortugalT
EP3527574A1European Patent Office (EPO)A1
TR2019011032T4TürkiyeT4
TR201911032T4TürkiyeT4
RU2017143776A3Russian FederationA3
PL3298021T3PolandT3
HUE045585T2HungaryT2
ES2739749T3SpainT3
US10562925B2United States of AmericaB2
CN107849073BChinaB
HK1251941BHong Kong, ChinaB
US2020131210A1United States of AmericaA1
JP6695940B2JapanB2
CN111349118AChinaA
CY1121851T1CyprusT1
JP2020128387AJapanA
AU2016264212B2AustraliaB2
AU2021200343A1AustraliaA1
JP6883688B2JapanB2
RU2752729C2Russian FederationC2
JP2021120392AJapanA
US2021261585A1United States of AmericaA1
IL255465BThis recordIsraelB
EP3527574B1European Patent Office (EPO)B1
DK3527574T3DenmarkT3
ES2921350T3SpainT3
JP7133680B2JapanB2
BR112017024933A8BrazilA8
EP4086264A1European Patent Office (EPO)A1
CN111349118BChinaB
EP4086264B1European Patent Office (EPO)B1
KR102608921B1Republic of KoreaB1
MX380798BMexicoB